UFP Technologies, Inc.
General ticker "UFPT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.8B (TTM average)
UFP Technologies, Inc. follows the US Stock Market performance with the rate: 14.1%.
Estimated limits based on current volatility of 2.4%: low 252.79$, high 265.00$
Factors to consider:
- Total employees count: 4146 (+34.0%) as of 2024
- Top business risk factors: Inflation impact, Product liability, Acquisition/divestiture risks, Labor/talent shortage/retention, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [205.52$, 315.43$]
- 2025-12-31 to 2026-12-31 estimated range: [207.43$, 321.21$]
Financial Metrics affecting the UFPT estimates:
- Negative: with PPE of 31.1 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 16.04
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.57 > 6.04
- Positive: 42.53 < Shareholder equity ratio, % of 54.49 <= 64.17
- Positive: Inventory ratio change, % of 0.40 <= 0.82
- Positive: -14.19 < Investing cash flow per share per price, % of -11.06
Short-term UFPT quotes
Long-term UFPT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $353.79MM | $399.93MM | $504.31MM |
| Operating Expenses | $298.39MM | $342.26MM | $423.42MM |
| Operating Income | $55.40MM | $57.66MM | $80.90MM |
| Non-Operating Income | $-2.68MM | $-3.76MM | $-7.87MM |
| Interest Expense | $2.76MM | $3.65MM | $8.06MM |
| Income(Loss) | $52.72MM | $53.90MM | $73.03MM |
| Taxes | $10.93MM | $8.98MM | $14.04MM |
| Profit(Loss)* | $41.79MM | $44.92MM | $58.98MM |
| Stockholders Equity | $237.54MM | $286.09MM | $342.76MM |
| Inventory | $53.54MM | $70.19MM | $87.54MM |
| Assets | $378.19MM | $404.14MM | $629.00MM |
| Operating Cash Flow | $17.74MM | $41.33MM | $66.59MM |
| Capital expenditure | $13.78MM | $10.49MM | $9.66MM |
| Investing Cash Flow | $1.29MM | $-10.49MM | $-210.16MM |
| Financing Cash Flow | $-25.89MM | $-30.02MM | $152.39MM |
| Earnings Per Share** | $5.52 | $5.89 | $7.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.